Pacira BioSciences, Inc. (PCRX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$36.44
+0.04%
Mkt Cap $1.45B
Analyst Ratings
Buy
3
Hold
5
Sell
0
Price Target (20 analysts)
$31.67
Range $25.00 – $36.50
Implied Upside
-13.1%
Consensus $31.67 vs current $36.44